We have to be realistic, big pharma and deep pocke

We have to be realistic, big pharma and deep pockets will lead the way, GNBT cant compete in the US, China doesnt require FDA approval so we may have an opportunity but its a race and a limited time to succeed. A PR with a clear explanation why we are "special" may trigger the investment community , soon the Corona hype will slow down and business back to normal. Hopefully NASDAQ still on track and funding/institutional buying lined up. A rapid test kit could really boost revenue, vaccine will take time and increased competition will reduce possible profits.